Illinois CyberKnife is proud to commemorate the 20th anniversary of CyberKnifeÂ® technology this year. Developed in 1994 at Stanford by Dr. John Adler, the concept was conceived with the goal of treating tumors throughout the body with radiosurgery, a treatment that at the time was restricted to head and neck tumors.
- The prototype system developed by Dr. Adler was used from 1994 to 2001 at Stanford.
- The U.S. Food and Drug Administration approved the CyberKnife for treatment of tumors in the head and neck in 1999.
- In 2001, the FDA approved the technology for the treatment of tumors throughout the body.
Over the last 20 years, CyberKnife has been adopted internationally for the treatment of primary and metastatic tumors, including those in the lungs, brain, liver, kidney and prostate..
CyberKnife has evolved as a treatment method with expanded applications and the availability of long-term patient results to further demonstrate its efficacy. CyberKnife manufacturer, Accuray, reports that the system has been used in 40 countries to treat more than half a million patients to date.
To learn more about Illinois CyberKnife and how we treat different types of tumors and conditions, contact us.
This is not intended as medical advice to replace the expertise and judgment of your health care team. It is intended to help you and your family make informed decisions, together with your doctor.